Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

NCT00175643 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Actinic Keratoses

Interventions

DRUG: imiquimod

Sponsor

University of British Columbia

Collaborators

[object Object]
[object Object]